Nobel Biocare and Boston University announce philanthropic partnership
Boston, Massachusetts. Today, Nobel Biocare and Boston University agreed to a 10-year philanthropic partnership, effective July 1, 2022. Through this partnership, Nobel Biocare will provide $4 million ($400,000 per year) in products as an in-kind educational grant to the Henry M. Goldman School of Dental Medicine (GSDM) over the next decade. Students and residents at GSDM will have an opportunity to place and restore implants using this grant. Through this partnership, students and residents will receive dental implant components, regenerative products, tools, and prosthetics.
Nobel Biocare president Patrik Eriksson praised the agreement. "We are proud to partner with Boston University's prestigious Goldman School of Dental Medicine. Part of Nobel Biocare's philosophy of continuous innovation is ensuring tomorrow's dentists have access to a world-class portfolio of dental implant products.”
Goldman School of Dental Medicine Dean Cataldo Leone says, "This partnership between Boston University and Nobel Biocare is an ideal fit; both enjoy an international reputation of innovative research in life sciences. This partnership – and the material support it delivers – will prove beneficial in guiding the educational and clinical care components of our service mission through the next decade, and beyond."
ABOUT BOSTON UNIVERSITY HENRY M. GOLDMAN SCHOOL OF DENTAL MEDICINE
Boston University Henry M. Goldman School of Dental Medicine (www.bu.edu/dental) is a premier academic dental institution promoting excellence in dental education, research, oral healthcare, and community service to improve the overall health of the global population. With a faculty of more than 325 educators, clinicians, and researchers and more than 250 staff members, the school, which was founded in 1963, offers a full spectrum of predoctoral and postdoctoral education programs and a complete range of graduate programs and degrees to more than 800 students. The school has more than 8,000 alumni who live and practice around the world. Goldman School of Dental Medicine (www.bu.edu/dental) is a premier academic dental institution promoting excellence in dental education, research, oral healthcare, and community service to improve the overall health of the global population. With a faculty of more than 325 educators, clinicians, and researchers and more than 250 staff members, the school, which was founded in 1963, offers a full spectrum of predoctoral and postdoctoral education programs and a complete range of graduate programs and degrees to more than 800 students. The school has more than 8,000 alumni who live and practice around the world.
ABOUT ENVISTA
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, DEXIS, Ormco, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a broad range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
